These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

141 related articles for article (PubMed ID: 21801150)

  • 21. Synthesis and in vitro antiproliferative activity of new 11-aminoalkylamino-substituted 5H- and 6H-indolo[2,3-b]quinolines; structure-activity relationships of neocryptolepines and 6-methyl congeners.
    Wang L; Switalska M; Mei ZW; Lu WJ; Takahara Y; Feng XW; El-Sayed Iel-T; Wietrzyk J; Inokuchi T
    Bioorg Med Chem; 2012 Aug; 20(15):4820-9. PubMed ID: 22748378
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Synthesis and biological evaluation of quinoline derivatives as potential anti-prostate cancer agents and Pim-1 kinase inhibitors.
    Li K; Li Y; Zhou D; Fan Y; Guo H; Ma T; Wen J; Liu D; Zhao L
    Bioorg Med Chem; 2016 Apr; 24(8):1889-97. PubMed ID: 26979485
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Synthesis and in vitro antiproliferative effect of novel quinoline-based potential anticancer agents.
    Arafa RK; Hegazy GH; Piazza GA; Abadi AH
    Eur J Med Chem; 2013 May; 63():826-32. PubMed ID: 23584545
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Different cytotoxicities and cellular localizations of novel quindoline derivatives with or without boronic acid modifications in cancer cells.
    Yin R; Zhang M; Hao C; Wang W; Qiu P; Wan S; Zhang L; Jiang T
    Chem Commun (Camb); 2013 Oct; 49(76):8516-8. PubMed ID: 23942773
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Design, synthesis and biological evaluation of novel 5,6,7-trimethoxy-N-aryl-2-styrylquinolin-4-amines as potential anticancer agents and tubulin polymerization inhibitors.
    Mirzaei S; Eisvand F; Hadizadeh F; Mosaffa F; Ghasemi A; Ghodsi R
    Bioorg Chem; 2020 May; 98():103711. PubMed ID: 32179282
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Synthesis and biological evaluation of 2-quinolineacrylamides.
    Wang SW; Lin MH; Hsu FC; Chen MC; Liou JP; Liu YT; Chen SS; Lee HY
    Bioorg Med Chem; 2020 Feb; 28(3):115250. PubMed ID: 31924504
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Anti-angiogenesis therapy and gap junction inhibition reduce MDA-MB-231 breast cancer cell invasion and metastasis in vitro and in vivo.
    Zibara K; Awada Z; Dib L; El-Saghir J; Al-Ghadban S; Ibrik A; El-Zein N; El-Sabban M
    Sci Rep; 2015 Jul; 5():12598. PubMed ID: 26218768
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Design, synthesis and anticancer evaluation of novel tetrahydroquinoline derivatives containing sulfonamide moiety.
    Ghorab MM; Ragab FA; Hamed MM
    Eur J Med Chem; 2009 Oct; 44(10):4211-7. PubMed ID: 19540022
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Discovery of 1-benzoyl-3-cyanopyrrolo[1,2-a]quinolines as a new series of apoptosis inducers using a cell- and caspase-based high-throughput screening assay. Part 1: Structure-activity relationships of the 1- and 3-positions.
    Kemnitzer W; Kuemmerle J; Jiang S; Zhang HZ; Sirisoma N; Kasibhatla S; Crogan-Grundy C; Tseng B; Drewe J; Cai SX
    Bioorg Med Chem Lett; 2008 Dec; 18(23):6259-64. PubMed ID: 18952423
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Tetrazolylmethyl quinolines: Design, docking studies, synthesis, anticancer and antifungal analyses.
    Shaikh SKJ; Kamble RR; Somagond SM; Devarajegowda HC; Dixit SR; Joshi SD
    Eur J Med Chem; 2017 Mar; 128():258-273. PubMed ID: 28192709
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Structure-based discovery of novel 4-(2-fluorophenoxy)quinoline derivatives as c-Met inhibitors using isocyanide-involved multicomponent reactions.
    Nan X; Li HJ; Fang SB; Li QY; Wu YC
    Eur J Med Chem; 2020 May; 193():112241. PubMed ID: 32200199
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Cryptolepine and aromathecin based mimics as potent G-quadruplex-binding, DNA-cleavage and anticancer agents: Design, synthesis and DNA targeting-induced apoptosis.
    Yuan JM; Wei K; Zhang GH; Chen NY; Wei XW; Pan CX; Mo DL; Su GF
    Eur J Med Chem; 2019 May; 169():144-158. PubMed ID: 30875505
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Syntheses and anti-cancer activities of 2-[1-(indol-3-yl-/pyrimidin-5-yl-/pyridine-2-yl-/quinolin-2-yl)-but-3-enylamino]-2-phenyl-ethanols.
    Singh P; Kaur P; Luxami V; Kaur S; Kumar S
    Bioorg Med Chem; 2007 Mar; 15(6):2386-95. PubMed ID: 17275313
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Discovery of 1-benzoyl-3-cyanopyrrolo[1,2-a]quinolines as a new series of apoptosis inducers using a cell- and caspase-based high-throughput screening assay. 2: Structure-activity relationships of the 4-, 5-, 6-, 7- and 8-positions.
    Kemnitzer W; Kuemmerle J; Jiang S; Sirisoma N; Kasibhatla S; Crogan-Grundy C; Tseng B; Drewe J; Cai SX
    Bioorg Med Chem Lett; 2009 Jul; 19(13):3481-4. PubMed ID: 19467598
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Effects of lovastatin on proliferation and gap junctional intercellular communication of human breast cancer cell MCF-7].
    Zhou Y; Mi MT; Zhu JD; Zhang QY
    Ai Zheng; 2003 Mar; 22(3):257-61. PubMed ID: 12654181
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Molecular Docking, Antioxidant, Anticancer and Antileishmanial Effects of Newly Synthesized Quinoline Derivatives.
    Malghani Z; Khan AU; Faheem M; Danish MZ; Nadeem H; Ansari SF; Maqbool M
    Anticancer Agents Med Chem; 2020; 20(13):1516-1529. PubMed ID: 32416701
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Design, synthesis and pharmacological evaluation of novel substituted quinoline-2-carboxamide derivatives as human dihydroorotate dehydrogenase (hDHODH) inhibitors and anticancer agents.
    Vyas VK; Variya B; Ghate MD
    Eur J Med Chem; 2014 Jul; 82():385-93. PubMed ID: 24929289
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Design, synthesis and biological evaluation of 7-(aryl)-2,3-dihydro-[1,4]dioxino[2,3-g]quinoline derivatives as potential Hsp90 inhibitors and anticancer agents.
    Malayeri SO; Abnous K; Arab A; Akaberi M; Mehri S; Zarghi A; Ghodsi R
    Bioorg Med Chem; 2017 Feb; 25(3):1294-1302. PubMed ID: 28073608
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Pyrazolo[3,4-h]quinolines promising photosensitizing agents in the treatment of cancer.
    Spanò V; Parrino B; Carbone A; Montalbano A; Salvador A; Brun P; Vedaldi D; Diana P; Cirrincione G; Barraja P
    Eur J Med Chem; 2015 Sep; 102():334-51. PubMed ID: 26295175
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Potential antitumor agents. 37. Synthesis and antitumor activity of guanylhydrazones from imidazo[2,1-b]thiazoles and from the new heterocyclic system thiazolo[2',3':2,3]imidazo[4,5-c]quinoline.
    Andreani A; Granaiola M; Leoni A; Locatelli A; Morigi R; Rambaldi M; Lenaz G; Fato R; Bergamini C; Farruggia G
    J Med Chem; 2005 Apr; 48(8):3085-9. PubMed ID: 15828848
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.